Director Program Manager, Product Launch (Rare Disease)

Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tHI) The Director Program Manager will be a key member of the Program Management Office (PMO), responsible for Launch execution plan for the company’s first rare disease drug launch. This individual will partner closely with key stakeholders and executives from Commercial, Medical Affairs, Regulatory, Manufacturing, Supply Chain to ensure operational readiness and alignment on critical path deliverables. This role requires a proactive leader with exceptional organizational skills, strategic thinking, and the ability to influence without direct authority in a fast-paced, evolving environment. Location: Redwood City California (in office role with travel as needed)